论文部分内容阅读
目的探讨红花黄色素注射液联合西药治疗脑梗死的临床效果。方法选取2013年12月至2014年12月内蒙古锡林郭勒盟蒙医综合医院收治的脑梗死患者100例为研究对象,按随机数字表法分为对照组和试验组,每组50例。对照组患者给予常规治疗,试验组患者在常规治疗的基础上加用红花黄色素注射液进行治疗。结果试验组患者在中医证候积分疗效方面与对照组比较,差异无统计学意义(P>0.05);试验组患者在神经功能缺损程度以及中医证候积分的改善情况明显优于对照组,差异有统计学意义(P<0.05)。结论红花黄色素注射液联合西药治疗脑梗死具有很好的临床治疗效果,对患者的神经功能缺损情况具有明显的治疗作用。
Objective To investigate the clinical effects of safflor yellow injection and western medicine in treating cerebral infarction. Methods A total of 100 patients with cerebral infarction admitted from Inner Mongolia Xilinguole Meng Mong General Hospital from December 2013 to December 2014 were selected and divided into control group and trial group according to random number table. Patients in the control group were given routine treatment. Patients in the test group were treated with safflower yellow injection on the basis of conventional treatment. Results Compared with the control group, there was no significant difference between the two groups (P> 0.05). The degree of neurological deficit and TCM syndrome score in the experimental group were significantly better than those in the control group There was statistical significance (P <0.05). Conclusion Safflower yellow injection combined with western medicine has a good clinical curative effect on cerebral infarction and has a significant therapeutic effect on patients with neurological deficits.